Wednesday, 3 May 2023

Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial

Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial submitted by /u/cnbc_official
[link] [comments]


from Health https://ift.tt/Thi6wtO
via IFTTT

No comments:

Post a Comment